Natural Evolution of AV Conduction Disorders in Patients Implanted With Cardiac Pacemakers


Observational study to assess AV block incidence and their evolution according to paroxysmal atrial arrhythmia.

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: December 2011

Clinical Trial Outcome Measures

Primary Measures

  • High degree AV blocks
    • Time Frame: 2 years

Participating in This Clinical Trial

Inclusion Criteria

  • Sinus Node Disease – Brady-Tachy Syndrome – Suspected or documented paroxysmal AVB Exclusion Criteria:

  • Permanent high degree AVB – Contra indication to the SafeR pacing mode – PR higher than 350 ms

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • LivaNova
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • DEHARO Jean Claude, MD, Principal Investigator, CHU la Timone – Marseille

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.